Literature DB >> 26137113

Expression of L1 protein correlates with cluster of differentiation 24 and integrin β1 expression in gastrointestinal stromal tumors.

Yue DU1, Haihong Zhang1, Zhongmin Jiang2, Guowei Huang1, Wenli Lu1, Hesheng Wang1.   

Abstract

The present study examined 66 cases of gastrointestinal stromal tumors (GISTs), 20 cases of smooth muscle tumors, 20 cases of schwannomas and 20 cases of normal gastric tissues in order to analyze the expression of L1, cluster of differentiation (CD)24 and integrin β1 by immunohistochemical staining. Patients were subjected to follow-up, and survival data were evaluated. L1 expression was detected in 57.6% of GIST cases; this was a significantly higher percentage compared with that found in the smooth muscle tumor cases or the normal control group. CD24 and integrin β1 were also expressed at significantly higher levels in the GIST cases than in the normal control group, although no significant difference was found in the expression levels of these proteins in smooth muscle tumor or schwannoma cases. These higher levels of L1 and integrin β1 expression were associated with an increased risk of invasive GIST, and were significantly positively correlated with Ki-67 expression. CD24 expression was not associated with the risk of GIST invasion or Ki-67 expression. There were positive correlations between L1, CD24 and integrin β1 expression; however, these had no significant association with patient survival. Therefore, L1 alone or in conjunction with CD24 (L1 + CD24), or integrin β1 (L1 + integrin β1) can be considered a valuable indicator for the differential diagnosis of GIST. Furthermore, L1 and integrin β1 can be used alone or in combination to evaluate the biological behavior of GISTs. Future studies are required to evaluate the prognostic value of these markers.

Entities:  

Keywords:  L1; cluster of differentiation 24; gastrointestinal stromal tumor; integrin β1

Year:  2015        PMID: 26137113      PMCID: PMC4473498          DOI: 10.3892/ol.2015.3096

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  40 in total

1.  Retrospective analysis of extra-gastrointestinal stromal tumors.

Authors:  Jun Ho Yi; Byeong-Bae Park; Jung Hun Kang; In Gyu Hwang; Dong Bok Shin; Sun Jin Sym; Hee Kyung Ahn; Soon Il Lee; Do Hyoung Lim; Keon Woo Park; Young-Woong Won; Sung Hee Lim; Se Hoon Park
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 2.  Progress in new diagnosis and therapeutic strategy for gastrointestinal malignancy: focus on new molecular-targeted treatments.

Authors:  Toshiro Sugiyama
Journal:  Digestion       Date:  2015-01-20       Impact factor: 3.216

3.  CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.

Authors:  Min-Cheng Su; Chiun Hsu; Hsin-Lien Kao; Yung-Ming Jeng
Journal:  Cancer Lett       Date:  2005-08-25       Impact factor: 8.679

Review 4.  The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy.

Authors:  Eyal Sagiv; Nadir Arber
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2008-02       Impact factor: 3.869

Review 5.  L1 cell adhesion molecule (L1CAM) in invasive tumors.

Authors:  Shani Raveh; Nancy Gavert; Avri Ben-Ze'ev
Journal:  Cancer Lett       Date:  2009-01-13       Impact factor: 8.679

6.  Lewis(x) and alpha2,3-sialyl glycans and their receptors TAG-1, Contactin, and L1 mediate CD24-dependent neurite outgrowth.

Authors:  Annika Lieberoth; Frauke Splittstoesser; Nainesh Katagihallimath; Igor Jakovcevski; Gabriele Loers; Barbara Ranscht; Domna Karagogeos; Melitta Schachner; Ralf Kleene
Journal:  J Neurosci       Date:  2009-05-20       Impact factor: 6.167

7.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

Review 8.  [Medical therapy of GIST; from palliative to curative treatment].

Authors:  Axel Le Cesne; Jean-Yves Blay
Journal:  Bull Acad Natl Med       Date:  2012 Apr-May       Impact factor: 0.144

9.  Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.

Authors:  Evelyne Bareck; Ahmed Ba-Ssalamah; Thomas Brodowicz; Wolfgang Eisterer; Michael Häfner; Christoph Högenauer; Ulrike Kastner; Thomas Kühr; Friedrich Längle; Bernadette Liegl-Atzwanger; Sebastian F Schoppmann; Gerlig Widmann; Fritz Wrba; Johannes Zacherl; Ferdinand Ploner
Journal:  Wien Med Wochenschr       Date:  2013-03-19

10.  The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.

Authors:  Alexandra Moulla; Dimosthenis Miliaras; Antonia Sioga; Aikaterini Kaidoglou; Louisa Economou
Journal:  Pol J Pathol       Date:  2013-10       Impact factor: 1.072

View more
  3 in total

1.  Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors.

Authors:  Shingo Inaguma; Zengfeng Wang; Jerzy P Lasota; Markku M Miettinen
Journal:  Oncotarget       Date:  2016-08-23

Review 2.  Prognostic significance of L1 cell adhesion molecule in cancer patients: A systematic review and meta-analysis.

Authors:  Teng Hua; Shuangge Liu; Xiaoyan Xin; Zhishan Jin; Qibin Liu; Shuqi Chi; Xiaoxiao Wang; Hongbo Wang
Journal:  Oncotarget       Date:  2016-12-20

3.  Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.

Authors:  Li Wang; Jialin Qu; Yu Liang; Deze Zhao; Faisal Ul Rehman; Kang Qin; Xiaochun Zhang
Journal:  Thorac Cancer       Date:  2020-02-14       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.